Drug Development

Research into Cold Cancers Heating Up

Accurately targeted immunotherapies through reliable neoantigen recognition enable personalized medicine development.

Development of Gamma-Delta T-Cell Therapies

Activation and expansion are essential for success in both autologous and allogeneic therapies.

QbD for Small-Molecule Continuous Process Development

Continuous manufacturing and a quality-by-design development approach are a natural fit.

FDA Gives Guidance on Developing Treatments for Early Alzheimer’s

March 15, 2024

The draft guidance document provides support to sponsors with drugs in clinical development that treat the states of sporadic Alzheimer’s disease.

Chime Biologics to Manufacture Novel Antibody Cancer Immunotherapy for Domain Therapeutics

March 14, 2024

In a new manufacturing pact, Chime Biologics will produce DT-7012, Domain Therapeutics' antibody candidate for treating cancer that will soon be entering Phase I studies.

Webcasts

From Lab to Launch: Successful Drug Development Strategies Using Lipid-Based Delivery Systems

March 14, 2024

Webinar Date/Time: Wed, Apr 24, 2024 11:00 AM EDT

EMA Validates Parallel Applications for Datopotamab Deruxtecan in Two Types of Cancer

March 08, 2024

EMA has validated two MAAs submitted by AstraZeneca and Daiichi Sankyo for datopotamab deruxtecan in two types of cancer.

J&J Completes $2 Billion Ambrx Acquisition, Boosts Pipeline for Next-Gen ADCs

March 07, 2024

Johnson & Johnson’s $2 billion acquisition of Ambrx boosts its pipeline of next-generation ADCs for cancer treatment.

Webcasts

Microdosing: A Powder-in-Capsule Technology Pathway from Development to Commercialization

March 07, 2024

Webinar Date/Time: Tue, Mar 26, 2024 11:00 AM EDT

AbbVie Partners with OSE Immunotherapeutics on Novel mAb for Chronic Inflammation

March 06, 2024

Under a global license and collaboration agreement, AbbVie and OSE Immunotherapeutics will aim to develop OSE-230, a mAb for treating chronic inflammation.

Webcasts

Examining Contamination Control Strategy in Primary Packaging - A Case Study

March 06, 2024

Webinar Date/Time: Tue, Apr 9, 2024 11:00 AM EDT

Webcasts

Transferring Energy to Hot Melt Extrusions

March 06, 2024

Webinar Date/Time: Friday, April 5, 2024 at 11amEDT | 10am CDT | 8am PDT

Research into Cold Cancers Heating Up

March 04, 2024

Accurately targeted immunotherapies through reliable neoantigen recognition enable personalized medicine development.